Remedy Plan Therapeutics Overview
- Founded
- 2011
- Status
- Private
- Latest Deal Type
- Later Stage VC
- Latest Deal Amount
- $5.2M
- Investors
- 3
Remedy Plan Therapeutics General Information
Description
Developer of medical drugs designed to halt tumor growth and prevent cancer. The company's drugs disrupt cancer stem cells, enabling patients to get new innovative treatment to strop cancer growth without toxic side effects.
Contact Information
Website
Formerly Known As
Vitil Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
- 12111 Parklawn Drive, Room 120
- Rockville, MD 20852
- United States
+1 (510) 000-0000
Remedy Plan Therapeutics Timeline
Remedy Plan Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 12-Nov-2019 | $5.2M | 000.00 | 000.00 | Completed | Generating Revenue |
| 5. Later Stage VC (Series AA) | 08-Nov-2018 | 00.00 | 00.00 | 000.00 | Completed | Generating Revenue |
| 4. Grant | 21-Sep-2018 | 000 | 00.00 | Completed | Generating Revenue | |
| 3. Angel (individual) | 01-Jan-2017 | 00.00 | 00.00 | Completed | Generating Revenue | |
| 2. Seed Round | $100K | $100K | Completed | Generating Revenue | ||
| 1. Accelerator/Incubator | Completed | Generating Revenue |
Remedy Plan Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | |
| Series AA | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Remedy Plan Therapeutics Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Gregory Crimmins Ph.D | Founder, Board Member and Chief Executive Officer | ||
| Dennise Jesús-Díaz Ph.D | Chief Operating Officer |
Remedy Plan Therapeutics Board Members (3)
| Name | Representing | Role | Since |
|---|---|---|---|
| Alexandra Manick | Schooner Capital | Board Member | 000 0000 |
| Frank McCormick | Self | Board Member | 000 0000 |
| Gregory Crimmins Ph.D | Remedy Plan Therapeutics | Founder, Board Member and Chief Executive Officer | 000 0000 |
Remedy Plan Therapeutics Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Schooner Capital | Growth/Expansion | Minority | 000 0000 | 000000 0 | |
| Maryland Tech Council | Corporation | 000 0000 | 000000 0 | ||
| California Institute for Quantitative Biosciences | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |